Seeking Alpha

Cubist Pharmaceuticals prices its $700M senior note offering

Cubist Pharmaceuticals (CBST +2.1%) gains after pricing an increased offering of $700M in senior convertible notes.

The 2018 offering bears interest at 1.125% a year and the 2020 notes to pay 1.875% a year.

The notes will be convertible at approximately $82.43 per share, representing a premium of around 32.5% to Thursday's closing price.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs